Stock listing
Polaryx Therapeutics, Inc.
Selected listing: PLYX · NASDAQ · USD · US
Polaryx Therapeutics, Inc. (NASDAQ:PLYX), Commercial Services. Latest release Sep 1, 2026: Polaryx Therapeutics Appoints Dr. Will Charlton as Chief Medical…
- Ticker
- NASDAQ:PLYX
- Asset type
- Stock
- Sector
- Commercial Services
- Industry
- Miscellaneous Commercial Services
- Exchange
- NASDAQ
- Currency
- USD
About Polaryx Therapeutics, Inc.
The company focuses on developing innovative therapies in the biotechnology sector. Investors can find more information about its operations and performance on its dedicated public company page.
Latest news from Polaryx Therapeutics, Inc.
Polaryx Therapeutics Appoints Dr. Will Charlton as Chief Medical Officer
September 1, 2026
Polaryx Therapeutics Advances Operational Readiness for SOTERIA Phase 2 Basket Trial
August 25, 2026
Polaryx Therapeutics Announces Closing of $10 Million Private Placement Equity Financing to Support Launch of SOTERIA Phase 2 Basket Trial
May 28, 2026
Polaryx Therapeutics to Participate in National Tay-Sachs & Allied Diseases Association Annual Family Conference
April 23, 2026
Polaryx Therapeutics Receives U.S. FDA Fast Track Designations for All Four Indications to be Evaluated in the SOTERIA Basket Trial
April 21, 2026
Research Polaryx Therapeutics, Inc.
Polaryx Therapeutics, Inc. company profile
View the public company page for Polaryx Therapeutics, Inc. on 6ix.
Polaryx Therapeutics, Inc. news
Read company news and market updates connected to Polaryx Therapeutics, Inc..
Polaryx Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Polaryx Therapeutics, Inc..